share_log

Prestige Consumer Healthcare (NYSE:PBH) Sets New 12-Month Low at $49.81

Prestige Consumer Healthcare (NYSE:PBH) Sets New 12-Month Low at $49.81

威望消费者医疗保健公司(纽约证券交易所代码：PBH)将12个月新低定为49.81美元
Defense World ·  2022/09/24 04:51

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating)'s share price reached a new 52-week low on Thursday . The company traded as low as $49.81 and last traded at $49.81, with a volume of 18 shares traded. The stock had previously closed at $50.55.

周四，威望消费者医疗保健公司(NYSE：PBH-GET Rating)的股价创下52周来的新低。该公司股价一度跌至49.81美元，最新报49.81美元，成交量为18股。此前该股收盘价为50.55美元。

Analyst Ratings Changes

分析师评级发生变化

Separately, DA Davidson reaffirmed a "neutral" rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.50.

另外，DA Davidson在8月9日星期二的一份研究报告中重申了对Prestige Consumer Healthcare股票的“中性”评级。两名投资分析师对该股的评级为持有，三名分析师对该公司的评级为买入。根据MarketBeat.com的数据，该公司目前的共识评级为“适度买入”，共识目标价为80.50美元。

Get
到达
Prestige Consumer Healthcare
威望消费者医疗保健
alerts:
警报：

Prestige Consumer Healthcare Stock Down 0.8 %

威望消费者医疗保健类股下跌0.8%

The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.23 and a current ratio of 2.09. The firm has a fifty day moving average price of $55.14 and a 200 day moving average price of $55.41. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.50 and a beta of 0.55.

该公司的债务权益比率为0.93，速动比率为1.23，流动比率为2.09。该公司的50日移动平均价为55.14美元，200日移动平均价为55.41美元。该公司的市值为25亿美元，市盈率为12.61倍，聚乙二醇率为1.50倍，贝塔系数为0.55。

Institutional Trading of Prestige Consumer Healthcare

威望消费者医疗保健的机构交易

Several hedge funds have recently modified their holdings of PBH. BlackRock Inc. increased its stake in Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company's stock valued at $482,584,000 after purchasing an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. increased its stake in Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company's stock valued at $294,322,000 after purchasing an additional 59,740 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Prestige Consumer Healthcare by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company's stock valued at $182,552,000 after purchasing an additional 12,790 shares in the last quarter. State Street Corp increased its stake in Prestige Consumer Healthcare by 4.9% in the 2nd quarter. State Street Corp now owns 1,921,456 shares of the company's stock valued at $112,982,000 after purchasing an additional 89,131 shares in the last quarter. Finally, Macquarie Group Ltd. increased its stake in Prestige Consumer Healthcare by 4.4% in the 2nd quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company's stock valued at $110,984,000 after purchasing an additional 79,519 shares in the last quarter. 99.37% of the stock is owned by institutional investors and hedge funds.
几家对冲基金最近调整了对PBH的持股。贝莱德股份有限公司在第一季度增持了Prestige Consumer Healthcare 12.4%的股份。贝莱德股份有限公司在上个季度增持了1,004,337股后，目前持有该公司9,115,718股股票，价值482,584,000美元。先锋集团第一季度增持Prestige Consumer Healthcare股份1.1%。先锋集团目前持有该公司5,559,553股股票，价值294,322,000美元，上一季度又购买了59,740股。Dimension Fund Advisors LP在第一季度增持Prestige Consumer Healthcare的股份0.4%。Dimension Fund Advisors LP现在拥有该公司3,448,246股股票，价值182,552,000美元，上个季度又购买了12,790股。道富集团第二季度增持Prestige Consumer Healthcare股份4.9%。道富银行目前持有1,921,456股该公司股票，价值112,982,000美元，上一季度又购买了89,131股。最后，麦格理集团有限公司在第二季度将其在Prestige Consumer Healthcare的持股增加了4.4%。麦格理集团目前持有该公司1,887,479股股票，价值110,984,000美元，上一季度又购买了79,519股。99.37%的股票由机构投资者和对冲基金持有。

About Prestige Consumer Healthcare

关于Prestige Consumer Healthcare

(Get Rating)

(获取评级)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

威望消费者保健公司及其子公司在美国和国际上开发、制造、营销、分销和销售非处方药(OTC)健康和个人护理产品。该公司在北美OTC Healthcare和国际OTC Healthcare两个部门运营。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 免费获取StockNews.com关于Prestige Consumer Healthcare(PBH)的研究报告
  • MarketBeat：回顾一周9/19-9/23
  • 为什么特斯拉的股票保持弹性？
  • 好市多盈利后价格疲软是买入的好时机吗？
  • CrowdStrike是否会从增加每股收益指引中获得提振？
  • 小盘股的裁员是楼市的晴雨表吗？

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

获得《尊贵消费者保健日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Prestige Consumer Healthcare和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发